Matinas biopharma to present at two investment conferences in october 2023

Bedminster, n.j., sept. 28, 2023 (globe newswire) -- matinas biopharma (nyse american: mtnb), a clinical-stage biopharmaceutical company focused on redefining the intracellular delivery of small molecules and small oligonucleotides with its lipid nanocrystal (lnc) platform technology, announces that jerome d. jabbour, chief executive officer, will present a company overview and hold meetings with institutional investors at two upcoming investment conferences:
MTNB Ratings Summary
MTNB Quant Ranking